Parathion

tumor protein p53 ; Homo sapiens







23 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 32775440 Prediction of the Impact of Deleterious Nonsynonymous Single Nucleotide Polymorphisms on the Human RRM2B Gene: A Molecular Modeling Study. 2020 1
2 29126924 Suppression of p53R2 gene expression with specific siRNA sensitizes HepG2 cells to doxorubicin. 2018 Feb 5 1
3 29720963 Deoxyribonucleotide Triphosphate Metabolism in Cancer and Metabolic Disease. 2018 1
4 26208523 The 1,2-Diaminocyclohexane Carrier Ligand in Oxaliplatin Induces p53-Dependent Transcriptional Repression of Factors Involved in Thymidylate Biosynthesis. 2015 Oct 1
5 25086499 Akt and p53R2, partners that dictate the progression and invasiveness of cancer. 2014 Oct 2
6 23205301 dNTP Supply Gene Expression Patterns after P53 Loss. 2012 Nov 20 2
7 19728742 2.6 A X-ray crystal structure of human p53R2, a p53-inducible ribonucleotide reductase . 2009 Nov 24 1
8 19787260 Organophosphorous pesticides and estrogen induce transformation of breast cells affecting p53 and c-Ha-ras genes. 2009 Nov 1
9 19015526 ATM-mediated serine 72 phosphorylation stabilizes ribonucleotide reductase small subunit p53R2 protein against MDM2 to DNA damage. 2008 Nov 25 1
10 17210678 Ribonucleotide reductase small subunit p53R2 facilitates p21 induction of G1 arrest under UV irradiation. 2007 Jan 1 1
11 17390078 Gene expression signature of parathion-transformed human breast epithelial cells. 2007 May 1
12 15096505 Stable suppression of the R2 subunit of ribonucleotide reductase by R2-targeted short interference RNA sensitizes p53(-/-) HCT-116 colon cancer cells to DNA-damaging agents and ribonucleotide reductase inhibitors. 2004 Jun 25 1
13 15254427 p53-Dependent activation of a molecular beacon in tumor cells following exposure to doxorubicin chemotherapy. 2004 Sep 1
14 11862321 Suppression of mismatched mutation by p53: a mechanism for guarding genomic integrity. 2002 Jan 1
15 11929820 Tumor genotype-specific growth inhibition in vivo by antisense oligonucleotides against a polymorphic site of the large subunit of human RNA polymerase II. 2002 Apr 1 1
16 11406618 Neurons are protected from excitotoxic death by p53 antisense oligonucleotides delivered in anionic liposomes. 2001 Aug 24 1
17 11699407 Oligonucleotide enhanced cytotoxicity of Idarubicin for lymphoma cells. 2001 Jul 2
18 10626228 Localization of chloroacetaldehyde-induced DNA damage in human p53 gene by DNA polymerase fingerprint analysis. 1999 1
19 9234928 p53 interference and growth inhibition in p53-mutant and overexpressing endometrial cancer cell lines. 1997 Jul 2
20 9368180 Ex vivo treatment of bone marrow with phosphorothioate oligonucleotide OL(1)p53 for autologous transplantation in acute myelogenous leukemia and myelodysplastic syndrome. 1997 Oct 1
21 8648390 Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignancies. 1996 Apr 2
22 7557622 Combination anti-gene therapy targeting c-myc and p53 in ovarian cancer cell lines. 1995 Oct 1
23 8533158 The role of p53 in regulating genomic stability when DNA and RNA synthesis are inhibited. 1995 Oct 1